“…Furthermore, when hPDLSCs are cultured, they showed positive expression for the mesenchymal markers CD73, CD90, CD105, CD29, CD44, CD146 and CD166, and negative expression of monocyte (CD14) and hematopoietic (CD34, and CD45) markers, endothelial marker CD31 and adhe-sion markers CD66, CD144, and CD171. This immunophenotype profile, recognized as a hallmark of multipotency, highlights the differentiation potential of hPDLSCs into various lineages such as chondrocytes, neural cells, cardiomyocytes, and mostly osteoblasts and cementoblasts which are implied in sustaining the formation of new bone [18][19][20]. In addition, hPDLSCs exert a strong paracrine capacity by releasing several angiogenic, mitogenic, antiapoptotic, anti-inflammatory and antioxidative factors, which together are proposed as the main mechanisms in regulating tissue repair upon MSC transplantation [16,[21][22][23][24][25].…”